Milipertine
A serotonin receptor antagonist
| Milipertine | |
|---|---|
| |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Milipertine is a chemical compound that acts as a serotonin receptor antagonist. It is primarily known for its effects on the central nervous system and has been studied for its potential therapeutic applications in various psychiatric disorders.
Pharmacology[edit]
Milipertine functions by blocking the action of serotonin at its receptor sites. This action is believed to modulate neurotransmission in the brain, which can influence mood and behavior. The compound has been investigated for its potential use in treating conditions such as depression, anxiety disorders, and other mood-related disorders.
Mechanism of Action[edit]
Milipertine primarily targets the 5-HT2A receptor, a subtype of serotonin receptor. By antagonizing this receptor, Milipertine can alter the downstream signaling pathways that are involved in mood regulation and perception. This mechanism is similar to that of other antipsychotic and antidepressant medications that also target serotonin receptors.
Clinical Applications[edit]
While Milipertine has shown promise in preclinical studies, its clinical applications are still under investigation. The compound's ability to modulate serotonin pathways suggests potential benefits in treating major depressive disorder and generalized anxiety disorder. However, further clinical trials are necessary to establish its efficacy and safety profile.
Side Effects[edit]
As with many serotonin receptor antagonists, Milipertine may cause side effects such as drowsiness, dry mouth, and gastrointestinal disturbances. The severity and occurrence of these side effects can vary depending on the dosage and individual patient factors.
Research and Development[edit]
Research into Milipertine is ongoing, with studies focusing on its pharmacokinetics, optimal dosing regimens, and long-term effects. The compound's potential to be used in combination with other psychotropic drugs is also being explored to enhance therapeutic outcomes.
Related pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
